Treatment of hepatitis Delta

Clinical Liver Disease

Volumn 2, Issue 6, 2013, Pages 237-239

  Wedemeyer, Heiner ^a   Hardtke, Svenja ^a   Manns, Michael P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ALPHA INTERFERON; HEPATITIS B SURFACE ANTIGEN; NUCLEOSIDE DERIVATIVE; NUCLEOTIDE DERIVATIVE; PEGINTERFERON ALPHA; PRENYLATION INHIBITOR; PROTEIN INHIBITOR; RIBAVIRIN; TENOFOVIR; UNCLASSIFIED DRUG; ALANINE AMINOTRANSFERASE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; RECOMBINANT ALPHA INTERFERON; VIRUS RNA;

ANTIVIRAL THERAPY; DELTA AGENT HEPATITIS; DRUG EFFICACY; DRUG MEGADOSE; END STAGE LIVER DISEASE; HEPATITIS DELTA VIRUS; HUMAN; LIVER TRANSPLANTATION; MONOTHERAPY; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTEIN PRENYLATION; REINFECTION; REVIEW; RNA REPLICATION; HEPATITIS B; HYPERTRANSAMINASEMIA; MIXED INFECTION; PREVALENCE; SUPERINFECTION; VIRUS REPLICATION;

EID: 84890828620     PISSN: None     EISSN: 20462484     Source Type: Journal    
DOI: 10.1002/cld.254     Document Type: Review

References (10)

1. Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol 2010;7:31-40.
2. Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet 2011;378:73-85.
3. Kucirka LM, Farzadegan H, Feld JJ, Mehta SH, Winters M, Glenn JS, et al. Prevalence, correlates, and viral dynamics of hepatitis Delta among injection drug users. J Infect Dis 2010;202:845-852.
4. Mederacke I, Yurdaydin C, Dalekos GN, Bremer B, Erhardt A, Cakaloglu Y, et al. Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-alpha2a treatment. Antivir Ther 2012;17:305-312.
5. Niro GA, Rosina F, Rizzetto M. Treatment of hepatitis D. J Viral Hepat 2005;12:2-9.
6. Heidrich B, Manns MP, Wedemeyer H. Treatment options for hepatitis delta virus infection. Curr Infect Dis Rep 2013;15:31-38.
7. Farci P, Roskams T, Chessa L, Peddis G, Mazzoleni AP, Scioscia R, et al. Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis. Gastroenterology 2004;126:1740-1749.
8. Wedemeyer H, Yurdaydin C, Dalekos GN, Erhardt A, Cakaloglu Y, Degertekin H, et al. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med 2011;364:322-331.
9. Lau DT, Doo E, Park Y, Kleiner DE, Schmid P, Kuhns MC, Hoofnagle JH. Lamivudine for chronic delta hepatitis. Hepatology 1999;30:546-549.
10. Bordier BB, Ohkanda J, Liu P, Lee SY, Salazar FH, Marion PL, et al. In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus. J Clin Invest 2003;112:407-414.